Future Cardiol. 2012;8(4):647-670. Although redox-induced damage is likely involved in anthracycline-induced cardiotoxicity, some evidence suggests that it is not the only mechanism at play. Several ...

Dexrazoxane reduced the risk for cardiac events and clinical heart failure among women with breast cancer who underwent anthracycline chemotherapy, according to results of a systematic review and meta ...

Please provide your email address to receive an email when new articles are posted on . Black race was associated with 71% greater odds of chemotherapy-related cardiotoxicity vs. white or non-Black ...

Penile Cancer: EAU-ASCO Collaborative Guidelines Update Q and A Cancer and cardiovascular diseases are the two major causes of mortality, morbidity, and disability worldwide. The improvement in ...

The prevalence of subclinical cardiotoxicity identified by echocardiographic global longitudinal strain (GLS) in patients with breast cancer taking doxorubicin (Adriamycin) was similar whether ...

Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials – This next-generation ...

Trastuzumab-mediated cardiotoxicity was originally described in women with metastatic breast cancer. The incidence rates were 13% when the antibody was administered in combination with paclitaxel and ...

Cardiotoxicity underlies a third of failures in regulatory clearance, making it among the most significant hurdles in developing new drugs. 1 axoCells human iPSC-derived ventricular cardiomyocytes ...

Compared with White patients, Black and Hispanic patients who receive anthracycline chemotherapy for treatment of cancer are at increased risk for cardiotoxicity. Black and Hispanic patients who ...

When compared to cocaine exposure alone, cocaine and ethanol exposure in emergency department (ED) patients with acute drug overdose was significantly associated with higher occurrence of cardiac ...